MedTrace Logo

Genomic Determinants of Outcome in Cardiogenic Shock

NCT05728359 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-11-18

No results posted yet for this study

Summary

The aim of this project is to understand the heterogeneity of both the immune consequences and treatment responses in CS. We will explore this heterogeneity through identification of transcriptomic sub-phenotypes and their association with outcomes, including therapeutic responses.

Conditions

  • Cardiogenic Shock

Interventions

OTHER

Observational study

Blood sampling and clinical data collection

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Alastair Proudfoot · Barts Heath NHS trust

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-08
Primary Completion
2026-11-01
Completion
2026-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05728359 on ClinicalTrials.gov